Literature DB >> 9351456

Coagulation factor Xa induces endothelium-dependent relaxations in rat aorta.

P Schaeffer1, A M Mares, F Dol, F Bono, J M Herbert.   

Abstract

The relaxing effect of coagulation factor Xa on phenylephrine-contracted rat aortic rings was compared with the effect of thrombin and trypsin. All three proteases induced a dose-dependent relaxation in the presence of an intact endothelium. EC50 values were 3 +/- 1, 24 +/- 9, and 16 +/- 1 nmol/L for thrombin, trypsin, and factor Xa, respectively. Whereas thrombin induced rapid relaxations followed by partial recontraction, trypsin and factor Xa induced slower sustained effects. Factor Xa-induced relaxations were not affected by hirudin at high concentrations (1 mumol/L) but were abolished by DX9065A, a specific inhibitor of the catalytic activity of factor Xa. Furthermore, no relaxations to factor Xa could be elicited in the presence of the NO synthase inhibitor N omega-nitro-L-arginine methyl ester (100 mumol/L), whereas relaxations were not altered in the presence of the inactive enantiomer N omega-nitro-D-arginine methyl ester (100 mumol/L). Addition of factor Xa together with thrombin induced relaxations that were larger than those induced by thrombin alone, whereas factor Xa had no additional effects on trypsin-induced relaxations. Further-more, factor Xa relaxed thrombin-desensitized aortic rings but was ineffective in trypsin-desensitized tissues. These data suggest that factor Xa acts on a cleavable endothelial receptor that induces NO release, resulting in the relaxation of precontracted rat aortic rings. Factor Xa does not act through endothelial thrombin receptors but may activate another cleavable trypsin-sensitive receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351456     DOI: 10.1161/01.res.81.5.824

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  5 in total

1.  Factor Xa-A pleuripotential protease.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

2.  Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.

Authors:  J Herbert; F Bono; J Herault; C Avril; F Dol; A Mares; P Schaeffer
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

3.  Effects of factor Xa on the expression of proteins in femoral arteries from type 2 diabetic patients.

Authors:  Antonio J López-Farré; Pablo Rodriguez-Sierra; Javier Modrego; Antonio Segura; Naiara Martín-Palacios; Ana M Saiz; José J Zamorano-León; Juan Duarte; Javier Serrano; Guillermo Moñux
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

4.  Rivaroxaban improves vascular response in LPS-induced acute inflammation in experimental models.

Authors:  Armond Daci; Lorenzo Da Dalt; Rame Alaj; Shpejtim Shurdhiqi; Burim Neziri; Rrahman Ferizi; Giuseppe Danilo Norata; Shaip Krasniqi
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

5.  Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries.

Authors:  Ambra Villari; Giovanni Giurdanella; Claudio Bucolo; Filippo Drago; Salvatore Salomone
Journal:  Front Pharmacol       Date:  2017-07-18       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.